{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:16:13Z","timestamp":1789884973317,"version":"4.0.1"},"reference-count":352,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00913","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T10:52:12Z","timestamp":1536058332000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":114,"title":["A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research"],"prefix":"10.3389","volume":"9","author":[{"given":"Gareth J.","family":"Sanger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L. R.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00520-018-4131-3","article-title":"CINV: still troubling patients after all these years","volume":"26","author":"Aapro","year":"2018","journal-title":"Support Care Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/BF00258206","article-title":"High-dose dexamethasone for prevention of cisplatin-induced vomiting","volume":"7","author":"Aapro","year":"1981","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/annonc\/mdu101","article-title":"A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy","volume":"25","author":"Aapro","year":"2014","journal-title":"Ann. Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.coph.2006.07.004","article-title":"Making a case for domperidone in the treatment of gastrointestinal motility disorders","volume":"6","author":"Ahmad","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/BF01320319","article-title":"Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motility","volume":"31","author":"Alphin","year":"1986","journal-title":"Dig. Dis. Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1113\/jphysiol.1954.sp005229","article-title":"The distribution of substance P and 5-hydroxytryptamine in the central nervous system of the dog","volume":"126","author":"Amin","year":"1954","journal-title":"J. Physiol."},{"key":"B7","first-page":"359","article-title":"The role of tachykinins and the tachykinin NK1 receptor in nausea and emesis","volume-title":"Handbook of Experimental Pharmacology","author":"Andrews","year":"2004"},{"key":"B8","first-page":"97","article-title":"Vomiting: a gastro-intestinal tract defensive reflex","volume-title":"Pathophysiology of the Gut and Airways","author":"Andrews","year":"1993"},{"key":"B9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/0028-3908(93)90189-A","article-title":"Resiniferatoxin, an ultrapotent capsaicin analog has antiemetic properties in the ferret","volume":"32","author":"Andrews","year":"1993","journal-title":"Neuropharmacology"},{"key":"B10","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/0028-3908(87)90100-6","article-title":"Evidence for an extra-abdominal site of action for the 5-HT3 receptor antagonist BRL24924 in the inhibition of radiation-evoked emesis in the ferret","volume":"26","author":"Andrews","year":"1987","journal-title":"Neuropharmacology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/0165-6147(88)90106-X","article-title":"Neuropharmacology of emesis induced by anti-cancer therapy","volume":"9","author":"Andrews","year":"1988","journal-title":"Trends Pharmacol. Sci."},{"key":"B12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/978-3-319-27016-6_2","article-title":"The physiology and pharmacology of nausea and vomiting induced by anti-cancer chemotherapy in humans","volume-title":"Management of Chemotherapy-Induced Nausea and Vomiting: New Agents and New Uses of Current Agent","author":"Andrews","year":"2016"},{"key":"B13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejphar.2013.09.072","article-title":"Nausea and the quest for the perfect anti-emetic","volume":"722","author":"Andrews","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.gastro.2015.04.003","article-title":"Loss of interstitial cells of Cajal and patterns of gastric dysrhythmia in patients with chronic unexplained nausea and vomiting","volume":"149","author":"Angeli","year":"2015","journal-title":"Gastroenterology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of mirtazapine","volume":"7","author":"Anttila","year":"2001","journal-title":"CNS Drug Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00210-011-0704-0","article-title":"Interactions of recombinant human histamine H1, H2, H3, and H4 receptors with 34 antidepressants and antipsychotics","volume":"385","author":"Appl","year":"2012","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0006-8993(82)91127-1","article-title":"Electron microscopic immunocytochemical localization of substance P in the area postrema of rat","volume":"243","author":"Armstrong","year":"1982","journal-title":"Brain Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1476-5381.1966.tb01674.x","article-title":"Receptors mediating some actions of histamine","volume":"27","author":"Ash","year":"1966","journal-title":"Br. J. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1089\/jpm.2014.0030","article-title":"Olanzapine for intractable nausea and vomiting in palliative care patients not receiving chemotherapy","volume":"17","author":"Atkinson","year":"2014","journal-title":"J. Palliat. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/j.1399-6576.2004.00527.x","article-title":"Betamethasone does not prevent nausea and vomiting induced by ipecacuanha","volume":"48","author":"Axelsson","year":"2003","journal-title":"Acta Anaesthesiol. Scand."},{"key":"B21","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.clpt.2005.08.015","article-title":"Association of the ABCB1 3435C>T polymorphism with antiemetic efficacy of 5-hydroxytryptamine type 3 antagonists","volume":"78","author":"Babaoglu","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"B22","first-page":"72","article-title":"Experimental motion-sickness and attempts at therapy","volume":"5","author":"Babkin","year":"1946","journal-title":"Revue. Can. Biol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197909273011318","article-title":"Nabilone as an antiemetic (Letter)","author":"Baker","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1124\/jpet.106.118869","article-title":"In vitro pharmacology of clinically used central nervous system-active drugs as inverse H1 receptor agonists","volume":"322","author":"Bakker","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.autneu.2016.07.003","article-title":"What is nausea? A historical analysis of changing views","volume":"202","author":"Balaban","year":"2017","journal-title":"Auton. Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1345\/aph.18003","article-title":"Domperidone: a peripherally acting dopamine2-receptor antagonist","volume":"33","author":"Barone","year":"1999","journal-title":"Ann. Pharmacother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/1098612X12473466","article-title":"Mechanisms, causes, investigation and management of vomiting disorders in cats: a literature review","volume":"15","author":"Batchelor","year":"2013","journal-title":"J. Feline Med. Surg."},{"key":"B28","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1365-2885.2007.00877.x","article-title":"The pharmacokinetics of maropitant, a novel neurokinin type-1 receptor antagonist, in dogs","volume":"30","author":"Benchaoui","year":"","journal-title":"J.Vet. Pharmacol. Therap"},{"key":"B29","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/vr.161.13.444","article-title":"Efficacy of maropitant for preventing vomiting associated with motion sickness in dogs","volume":"161","author":"Benchaoui","year":"","journal-title":"Vet. Rec."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1176\/ajp.151.7.1084","article-title":"Cisapride for the treatment of nausea produced by selective serotonin reuptake inhibitors","volume":"151","author":"Bergeron","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/bjc.1988.277","article-title":"The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694","volume":"58","author":"Bermudez","year":"1988","journal-title":"Br. J. Cancer"},{"key":"B32","first-page":"363","article-title":"Occurrence of physaelamin in extracts of the skin of Physalaemus fuscumaculatus and its pharmacological actions on estavascular smooth muscle","volume":"25","author":"Bertaccini","year":"1965","journal-title":"Br. J. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fneur.2016.00014","article-title":"Moving in a moving world: a review on vestibular motion sickness","volume":"7","author":"Bertolini","year":"2016","journal-title":"Front. Neurol"},{"key":"B34","first-page":"239","article-title":"Resiniferatoxin: a broad spectrum antiemetic in the ferret","volume-title":"Mechanisms and Control of Emesis","author":"Bhandari","year":"1992"},{"key":"B35","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1476-5381.1968.tb08479.x","article-title":"Role of the chemoreceptor trigger zone in histamine-induced emesis","volume":"34","author":"Bhargava","year":"1968","journal-title":"Br. J. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/0014-2999(70)90085-3","article-title":"Effect of metoclopramide in isolated guinea-pig colon. 2. Interference with ganglionic stimulant drugs","volume":"12","author":"Bianchi","year":"1970","journal-title":"Eur. J. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/bmj.1.4591.13","article-title":"Antihistamine drugs in treatment of nausea and vomiting due to streptomycin","volume":"1","author":"Bignall","year":"1949","journal-title":"Br. Med. J."},{"key":"B38","first-page":"13","article-title":"The effects of metoclopramide on some isolated intestinal preparations","volume":"49","author":"Birtley","year":"1973","journal-title":"Postgrad. Med. J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2940317","DOI":"10.5056\/jnm14060","article-title":"The significance of interstitial cells in neurogastroenterology","volume":"20","author":"Blair","year":"2014","journal-title":"J. Neurogastroenterol. Motil"},{"key":"B40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0165-6147(92)90051-7","article-title":"The 5-HT4 receptor: a place in the sun","volume":"13","author":"Bockaert","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"B41","first-page":"45","article-title":"On the therapeutic value of metoclopramide. Apropos of 2,300 cases. Critical review and indications for its use","volume":"7","author":"Boisson","year":"1966","journal-title":"Cah. Coll. Med. Hop. Paris"},{"key":"B42","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1124\/jpet.302.1.328","article-title":"A novel phenylaminotetralin radioligand reveals a subpopulation of histamine H(1) receptors","volume":"302","author":"Booth","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B43","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0301-0082(89)90028-2","article-title":"Area postrema: chemoreceptor circumventricular organ of the medulla oblongata","volume":"32","author":"Borison","year":"1989","journal-title":"Prog. Neurobiol"},{"key":"B44","first-page":"7","article-title":"Neuropharmacologic mechanisms of emesis. Chapter 2","volume-title":"Antiemetics and Cancer Therapy","author":"Borison","year":"1983"},{"key":"B45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0031-6997(25)07328-4","article-title":"Physiology and pharmacology of vomiting","volume":"5","author":"Borison","year":"1953","journal-title":"Pharmacol. Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.drudis.2012.05.004","article-title":"Decision-making using fMRI in clinical drug development: revisiting NK-1 receptor antagonists for pain","volume":"17","author":"Borsook","year":"2012","journal-title":"Drug Discov. Today"},{"key":"B47","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1016\/0014-2999(93)90673-6","article-title":"Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferrets","volume":"249","author":"Bountra","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"B48","first-page":"303","article-title":"Prevention of apomorphine-induced vomiting (dimethyl amino-1-n-propyl-3)-N-(2-chloro)-phenothiazine hydrochloride","volume":"12","author":"Boyd","year":"1953","journal-title":"Fed. Proc."},{"key":"B49","first-page":"276","article-title":"The antiemetic action of chlorpromazine hydrochloride","volume":"70","author":"Boyd","year":"1954","journal-title":"Can. Med. Assoc. J."},{"key":"B50","first-page":"418P","article-title":"Different anticancer therapies evoke emesis by mechanisms that could be blocked by the 5-HT3 receptor antagonist, BRL 43694","volume":"91","author":"Boyle","year":"1987","journal-title":"Br. J. Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/0028-3908(86)90207-8","article-title":"Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine","volume":"25","author":"Bradley","year":"1986","journal-title":"Neuropharmacology"},{"key":"B52","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0022-3565(25)04467-2","article-title":"The anti-emetic activity of 10-(7-dimethylaminopropyl)-2-chlorophenpthiazine (chlorpromazine) in dog and cat","volume":"110","author":"Brand","year":"1954","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B53","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0031-6997(25)07243-6","article-title":"Drugs used in motion sickness. A critical review of the methods available for the study of drugs of potential value in its treatment and of the information which has been derived by these methods","volume":"18","author":"Brand","year":"1966","journal-title":"Pharmacol. Rev."},{"key":"B54","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0031-6997(25)06935-2","article-title":"Gastrointestinal prokinetic benzamides: the pharmacology underlying stimulation of motility","volume":"47","author":"Briejer","year":"1995","journal-title":"Pharmacol. Rev."},{"key":"B55","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/nmo.12338","article-title":"Drugs acting at 5-HT4, D2, motilin and ghrelin receptors differ markedly in how they affect neuromuscular functions in human isolated stomach","volume":"26","author":"Broad","year":"2014","journal-title":"Neurogastroenterol. Motil."},{"key":"B56","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/j.1476-5381.2012.02009.x","article-title":"Regional- and agonist-dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists","volume":"167","author":"Broad","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/bph.12077","article-title":"The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin","volume":"168","author":"Broad","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"360","DOI":"10.2165\/00003495-198224050-00002","article-title":"Domperidone","volume":"24","author":"Brogden","year":"1982","journal-title":"Drugs"},{"key":"B59","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0002-9378(97)80032-4","article-title":"Profet, profits, and proof: do nausea and vomiting of early pregnancy protect women from \u201charmful\u201d vegetables?","volume":"176","author":"Brown","year":"1997","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B60","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0022-3565(25)30548-3","article-title":"The effects of metoclopramide in modifying the response of isolated guinea-pig ileum to various agonists","volume":"197","author":"Bury","year":"1976","journal-title":"J. Pharm. Exp. Ther."},{"key":"B61","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/nmo.12490","article-title":"Emerging treatments in neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist","volume":"27","author":"Camilleri","year":"2015","journal-title":"Neurogastroenterol. Motil."},{"key":"B63","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ajg.2012.373","article-title":"Clinical guideline: management of gastroparesis","volume":"108","author":"Camilleri","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1600-0773.1963.tb01730.x","article-title":"Effect of chlorpromazine and haloperidol on the formation of 3-methoxytrytamine and normetanephrine in mouse brain","volume":"20","author":"Carlsson","year":"1963","journal-title":"Acta Pharmacol. Toxicol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/BF00735276","article-title":"Responses of neurons of canine area postrema to neurotransmitters and peptides","volume":"3","author":"Carpenter","year":"1983","journal-title":"Cell. Mol. Neurobiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0166-4328(84)90220-1","article-title":"Peptide-induced emesis in dogs","volume":"11","author":"Carpenter","year":"1984","journal-title":"Behav. Brain Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/bjc.1988.278","article-title":"Pharmacokinetics and anti-emetic efficacy of BRL43694, a new 5-HT3 antagonist","volume":"58","author":"Cassidy","year":"1988","journal-title":"Br. J. Cancer"},{"key":"B68","volume-title":"Modern Strategy for Preclinical Pharmaceutical R&D: Towards the Virtual Research Company","author":"Cavella","year":"1997"},{"key":"B69","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1021\/jm00182a013","article-title":"4-Piperazinyl-1OH-thieno[2,3-b][1,5)benzodiazepines as potential neuroleptics","volume":"23","author":"Chakrabarti","year":"1980","journal-title":"J. Med. Chem"},{"key":"B70","first-page":"457","article-title":"Domperidone, a new dopamine antagonist","volume":"135","author":"Champion","year":"1986","journal-title":"CMA J."},{"key":"B71","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/j.1365-2982.2007.01023.x","article-title":"Diabetes and the enteric nervous system","volume":"19","author":"Chandrasekharan","year":"2007","journal-title":"Neurogastroenterol. Motil."},{"key":"B72","unstructured":"ChazotP. LeursR. HillS. J. FukuiH. GanellinC. R. HaasH. L. Histamine Receptors. IUPHAR\/BPS Guide to Pharmacology2017"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.neuroimage.2006.06.059","article-title":"Pharmacological MRI in awake rats reveals neural activity in area postrema and nucleus tractus solitatrius: relevance of a potential biomarker for detecting drug-induced emesis","volume":"33","author":"Chin","year":"2006","journal-title":"NeuroImage"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1007\/s00520-016-3075-8","article-title":"Efficacy of olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis","volume":"24","author":"Chiu","year":"2016","journal-title":"Support Care Cancer"},{"key":"B75","volume-title":"The Discovery, Use and Impact of Platinum Salts as Chemotherapy Agents for Cancer. Wellcome Witnesses to Twentieth Century Medicine","author":"Christie","year":"2007"},{"key":"B76","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejphar.2013.10.008","article-title":"The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting","volume":"722","author":"Chu","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4103\/0019-5154.110832","article-title":"Pharmacology of antihistamines","volume":"58","author":"Church","year":"2013","journal-title":"Ind. J. Dermatol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1021\/jm00070a008","article-title":"2-(Quinuclidin-3-yl)pyrido[4,3-b]indol-1-ones andisoquinolin-1-ones. Potent conformationally restricted 5-HT3 receptor antagonists","volume":"36","author":"Clark","year":"1993","journal-title":"J. Med. Chem."},{"key":"B79","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0014-2999(71)90139-7","article-title":"Side effects of anti-emetics: results of a class experiment","volume":"14","author":"Clarke","year":"1971","journal-title":"Eur. J. Pharmacol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1111\/jvim.12414","article-title":"Effects of maropitant citrate or acepromazine on the incidence of adverse events associated with hydromorphone premedications in dogs","volume":"28","author":"Claude","year":"2014","journal-title":"J. Vet. Intern. Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0006-8993(81)91302-0","article-title":"The regional distribution of somatostatin, substance P and neurotensin in human brain","volume":"218","author":"Cooper","year":"1981","journal-title":"Brain Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"305","DOI":"10.5056\/jnm.2011.17.3.305","article-title":"Psychiatric co-morbidity and efficacy of mirtazapine treatment in young subjects with chronic or cyclic vomiting syndromes: a case series","volume":"17","author":"Coskun","year":"2011","journal-title":"J. Neurogastroenterol. Motil."},{"key":"B83","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/0028-3908(86)90030-4","article-title":"5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis","volume":"25","author":"Costall","year":"1986","journal-title":"Neuropharmacology"},{"key":"B84","first-page":"305","article-title":"The pharmacology of 3-chloro-10-(3-dimethylaminopropyl)phenothiazine-HCl. A substance which potentiates anesthetics and causes hibernation","volume":"92","author":"Courvoisier","year":"1953","journal-title":"Arch. Intern. Pharmacodynam. Ther."},{"key":"B85","first-page":"29","article-title":"Neurophysiology of motion sickness","volume-title":"Motion and Space Sickness","author":"Crampton","year":"1990"},{"key":"B86","first-page":"1063","article-title":"Effect of the non-antidopaminergic drug cisapride on postprandial nausea","volume":"36","author":"Creytens","year":"1984","journal-title":"Curr. Ther. Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S0885-3924(97)00079-1","article-title":"Use of ondansetron in palliative medicine","volume":"13","author":"Currow","year":"1997","journal-title":"J. Pain Symptom Manage."},{"key":"B88","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0009-9260(79)80203-2","article-title":"The acute radiation syndrome","volume":"30","author":"Danjoux","year":"1979","journal-title":"Clin. Radiol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0091-3057(01)00531-7","article-title":"Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB(1) receptors in the least shrew","volume":"69","author":"Darmani","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B90","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-3-642-70479-6_6","article-title":"The organisation of vomiting as a protective reflex: a commentary on the first day's discussions","volume-title":"Nausea and Vomiting: Mechanisms and Treatment","author":"Davis","year":"1986"},{"key":"B91","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2460\/ajvr.68.1.48","article-title":"Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusions of cisplatin in dogs","volume":"68","author":"de la Puente-Redondo","year":"2007","journal-title":"Am. J. Vet. Res"},{"key":"B92","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/bja\/82.2.274","article-title":"Anti-emetic activity of NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery","volume":"82","author":"Diemunsch","year":"1999","journal-title":"Br. J. Anaesth"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1472-684X-12-2","article-title":"Evidence for the use of levomepromazine for symptom control in the palliative care setting: a systematic review","volume":"12","author":"Dietz","year":"2013","journal-title":"BMC Palliat. Care"},{"key":"B94","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/S0009-9236(98)90140-0","article-title":"The substance P receptor antagonist CP-99,994 reduces acute postoperative pain","volume":"64","author":"Dionne","year":"1998","journal-title":"Clin. Pharmacol. Ther"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1007\/s00520-015-3071-4.","article-title":"Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysis","volume":"24","author":"Donovan","year":"2016","journal-title":"Support Care Cancer"},{"key":"B96","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1113\/jphysiol.1951.sp004661","article-title":"Distribution of histamine and substance P in the wall of the dog's digestive tract","volume":"115","author":"Douglas","year":"1951","journal-title":"J. Physiol. (Lond)."},{"key":"B97","first-page":"880","article-title":"A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system","volume":"34","author":"Dumuis","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/j.1476-5381.1995.tb13283.x","article-title":"Pharmacological characterization of RS 25259-197, a novel and selective 5-HT3 receptor antagonist, in vivo","volume":"114","author":"Eglen","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2222.1999.00005.x","article-title":"Histamine and the antiallergic antihistamines: a history of their discoveries","volume":"29","author":"Emanuel","year":"1999","journal-title":"Clin. Exp. Allergy"},{"key":"B100","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.2042-7158.1980.tb12961.x","article-title":"The dopamine receptor antagonist domperidone is also a competitive antagonist at alpha 1-adrenoceptors","volume":"32","author":"Ennis","year":"1980","journal-title":"J. Pharm. Pharmacol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1476-5381.1963.tb01488.x","article-title":"The action of eledoisin on systemic arterial blood pressure of some experimental animals","volume":"20","author":"Erspamer","year":"1963","journal-title":"Br. J. Pharmacol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.2042-7158.1959.tb12603.x","article-title":"Observations on the release and turnover rate of 5-hydroxytryptamine in the gastrointestinal tract","volume":"11","author":"Erspamer","year":"1959","journal-title":"J. Pharm. Pharmacol."},{"key":"B103","first-page":"91","article-title":"Nausea and vomiting in pregnancy","volume":"7","author":"Fairweather","year":"1978","journal-title":"Obstet. Gynaecol. Annu"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/jcp.0b013e3181627b60","article-title":"Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics","volume":"28","author":"Fangmann","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1113\/jphysiol.2014.284240","article-title":"Visually induced nausea causes characteristic changes in cerebral, autonomic and endocrine function in humans","volume":"593","author":"Farmer","year":"2015","journal-title":"J. Physiol. (Lond)"},{"key":"B106","first-page":"397","article-title":"The enteric distribution of 5-hydroxytryptamine (enteramine, serotonin) in some large domestic mammals and the appearance of 5-hydroxytryptamine and the enterochromaffin cell system in the embryonic calf","volume":"16","author":"Faustini","year":"1955","journal-title":"Am. J. Vet. Res"},{"key":"B107","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1086\/393377","article-title":"Morning sickness: a mechanism for protecting mother and embryo","volume":"75","author":"Flaxman","year":"2000","journal-title":"Q. Rev. Biol"},{"key":"B108","first-page":"187","article-title":"Cisplatin-induced emesis in the ferret. A new animal model","volume":"66","author":"Floczyk","year":"1982","journal-title":"Cancer Treat. Rep."},{"key":"B109","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejon.2004.03.006","article-title":"Nausea: the neglected symptom?","volume":"9","author":"Foubert","year":"2005","journal-title":"Eur. J. Oncol. Nurs."},{"key":"B110","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0014-2999(83)90659-3","article-title":"Failure of 5-methoxytryptamine to evoke the Bezold-Jarisch effect supports homology of excitatory 5-HT receptors on vagal afferents and postganglionic sympathetic neurons","volume":"95","author":"Fozard","year":"1983","journal-title":"Eur. J. Pharmacol."},{"key":"B111","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF00518776","article-title":"MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors","volume":"326","author":"Fozard","year":"1984","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B112","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00507041","article-title":"Receptors for 5-hydroxytryptamine on the sympathetic nerves of the rabbit heart","volume":"301","author":"Fozard","year":"1978","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1001\/jama.1953.02940220024007a","article-title":"New antiemetic drug. Preliminary report","volume":"3","author":"Friend","year":"1953","journal-title":"J. Am. Med. Assoc."},{"key":"B114","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJM195406102502306","article-title":"Use of chlorpromazine in the treatment of nausea and vomiting of uremia","volume":"250","author":"Friend","year":"1954","journal-title":"N. Engl. J. Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1476-5381.1957.tb00142.x","article-title":"Two kinds of tryptamine receptor","volume":"12","author":"Gaddum","year":"1957","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"B116","first-page":"516P","article-title":"Anti-emetic activity of neurokinin NK1 receptor antagonists is mediated centrally in the ferret","volume":"112","author":"Gardner","year":"1994","journal-title":"Br. J. Pharmacol"},{"key":"B117","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.109.2832.359","article-title":"The prevention and treatment of motion sickness. 1. Seasickness","volume":"109","author":"Gay","year":"1949","journal-title":"Science"},{"key":"B118","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1097\/00000539-199802001-00032","article-title":"Comparison of a new NK-1 antagonist (CP-122,721) to ondansetron in the prevention of postoperative nausea and vomiting","volume":"86","author":"Gesztesi","year":"1998","journal-title":"Anaesth. Analg."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1136\/bmj.2.6050.1489","article-title":"Diseases of the alimentary system. Nausea and vomiting","volume":"2","author":"Gibbs","year":"1976","journal-title":"Br. Med. J."},{"key":"B120","first-page":"358","article-title":"Dual mechanism of anti-emetic action of 10-(\u03b3-dimethylaminopropyl)-2-chlorophenothiazine hydrochloride (chlorpromazine)","volume":"114","author":"Glaviano","year":"1955","journal-title":"J. Pharmacol. Exp.Ther."},{"key":"B121","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/BF00686242","article-title":"The 5-HT3 antagonist, BRL 43694, dose not compromise the efficacy of cisplatin in tumour-bearing mice","volume":"25","author":"Goddard","year":"1990","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/WCO.0000000000000163","article-title":"Pathophysiology and treatment of motion sickness","volume":"28","author":"Golding","year":"2015","journal-title":"Curr. Opin. Neurol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1046\/j.1365-2125.1997.00606.x","article-title":"Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate","volume":"43","author":"Golding","year":"1997","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B124","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/00003495-198300251-00007","article-title":"Metoclopramide. A review of antiemetic trials","volume":"25","author":"Gralla","year":"1983","journal-title":"Drugs"},{"key":"B125","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJM198110153051601","article-title":"Antiemetic efficacy of high dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting","volume":"305","author":"Gralla","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"B126","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00520-008-0511-4","article-title":"Undertreatment of nausea and other symptoms in hospitalized cancer patients","volume":"17","author":"Greaves","year":"2009","journal-title":"Support Care Cancer"},{"key":"B127","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1007\/s00221-014-3905-1","article-title":"Gabapentin's anti-nausea and anti-emetic effects: a review","volume":"232","author":"Guttuso","year":"2014","journal-title":"Exp. Brain Res"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/S0140-6736(03)13365-X","article-title":"Effect of gabapentin on nausea induced by chemotherapy in patients with breast cancer","volume":"361","author":"Guttuso","year":"2003","journal-title":"Lancet"},{"key":"B129","first-page":"61","article-title":"Antagonism of cisplatin-induced emesis in the dog","volume":"23","author":"Gylys","year":"1979","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"B130","first-page":"1446","article-title":"Radiation-induced emesis in ferrets: an experimental model of emesis","volume":"90","author":"Gylys","year":"1986","journal-title":"Gastroenterology"},{"key":"B131","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1021\/jm980299k","article-title":"Structural optimization affording 2-(R)-(1-(R)-3, 5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4-(3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonist","volume":"41","author":"Hale","year":"1998","journal-title":"J. Med. Chem."},{"key":"B132","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF00304763","article-title":"Differential interactions of traditional and novel antiemetics with dopamine D2 and 5-hydroxytryptamine3 receptors","volume":"24","author":"Hamik","year":"1989","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2165\/00003495-198325050-00002","article-title":"Metoclopramide. An updated review of its pharmacological properties and clinical use","volume":"25","author":"Harrington","year":"1983","journal-title":"Drugs"},{"key":"B134","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/978-3-642-70479-6_7","article-title":"Mechanism and treatment of cytotoxic\u2013induced nausea and vomiting","volume-title":"Nausea and Vomiting: Mechanisms and treatment","author":"Harris","year":"1986"},{"key":"B135","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11938-016-0110-2","article-title":"Newest drugs for chronic unexplained nausea and vomiting","volume":"14","author":"Hasler","year":"2016","journal-title":"Curr. Treat. Options Gastroenterol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1152\/physrev.1924.4.3.479","article-title":"The mechanism of vomiting","volume":"4","author":"Hatcher","year":"1924","journal-title":"Physiolog. Rev."},{"key":"B137","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-3565(25)05711-8","article-title":"Studies on vomiting","volume":"22","author":"Hatcher","year":"1923","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B138","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/bjc.1990.12","article-title":"Dexamethasone can potentiate the anti-emetic action of a 5HT3 receptor antagonist on cyclophosphamide induced vomiting in the ferret","volume":"61","author":"Hawthorn","year":"1990","journal-title":"Br. J. Cancer"},{"key":"B139","doi-asserted-by":"publisher","first-page":"e13246","DOI":"10.1111\/nmo.13246","article-title":"Therapeutic response to domperidone in gastroparesis: a prospective study using the GCSI-daily diary","volume":"30","author":"Heckert","year":"2018","journal-title":"Neurogastroenerol. Motil."},{"key":"B140","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0306-4522(84)90148-9","article-title":"Autoradiographic localization of substance P receptors in rat medulla: effect of vagotomy and nodose ganglionectomy","volume":"12","author":"Helke","year":"1984","journal-title":"Neurosci"},{"key":"B141","author":"Henry","year":"1939","journal-title":"The Plant Alkaloids"},{"key":"B142","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00520-016-3313-0","article-title":"Updated MASCC\/ESMO consensus recommendations: prevention of nausea and vomiting following high emetic risk chemotherapy","volume":"25","author":"Herrstedt","year":"2017","journal-title":"Support Care Cancer"},{"key":"B143","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1200\/JCO.1999.17.1.338","article-title":"Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11974 in the control of cisplatin-induced emesis","volume":"17","author":"Hesketh","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"B144","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/bmj.2.4409.6","article-title":"Prevention of sea-sickness in assault craft. A report of experiments under tropical conditions","volume":"2","author":"Hill","year":"1945","journal-title":"Br. Med. J."},{"key":"B145","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0165-6147(00)01502-9","article-title":"NK1 (substance P) receptor antagonists\u2013why are they not analgesic in humans?","volume":"21","author":"Hill","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00520-014-2138-y","article-title":"Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review","volume":"22","author":"Hocking","year":"2014","journal-title":"Support Care Cancer"},{"key":"B147","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/j.1471-4159.2008.05775.x","article-title":"Characterization of 5-HT3c, 5-HT3d and 5-HT3e receptor subunits: evolution, distribution and function","volume":"108","author":"Holbrook","year":"2009","journal-title":"J. Neurochem."},{"key":"B148","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/oxfordjournals.bmb.a073050","article-title":"Wartime investigations into sea-and airsickness","volume":"5","author":"Holling","year":"1947","journal-title":"Br. Med. Bull."},{"key":"B149","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0140-6736(00)42499-2","article-title":"Prevention of seasickness by drugs","volume":"1","author":"Holling","year":"1944","journal-title":"Lancet"},{"key":"B150","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/j.1476-5381.2009.00176.x","article-title":"Opportunities for the replacement of animals in the study of nausea and vomiting. Replacement in a multi-system reflex","volume":"167","author":"Holmes","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fnins.2011.00088","article-title":"Behavioural patterns associated with chemotherapy-induced emesis: a potential signature for nausea in musk shrews","volume":"5","author":"Horn","year":"2011","journal-title":"Front. Neurosci."},{"key":"B152","doi-asserted-by":"publisher","first-page":"e60537","DOI":"10.1371\/journal.pone.0060537","article-title":"Why can't rodents vomit? A comparative behavioral, anatomical, and physiological study","volume":"8","author":"Horn","year":"2013","journal-title":"PLoS ONE"},{"key":"B153","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejphar.2013.10.037","article-title":"Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting","volume":"722","author":"Horn","year":"2014","journal-title":"Eur. J. Pharmacol"},{"key":"B154","doi-asserted-by":"crossref","first-page":"106S","DOI":"10.1016\/S0002-9343(01)00849-X","article-title":"Central circuitry associated with emesis","volume":"111","author":"Hornby","year":"2001","journal-title":"Am. Med. J."},{"key":"B155","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1093\/hmg\/ddv028","article-title":"Genetic variants associated with motion sickness point to roles for inner ear development, neurological processes and glucose homeostasis","volume":"24","author":"Hromatka","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"B156","doi-asserted-by":"publisher","first-page":"E30","DOI":"10.1208\/ps030430","article-title":"Receptor binding studies of soft anticholinergic agents","volume":"3","author":"Huang","year":"2001","journal-title":"AAPS Pharm. Sci."},{"key":"B157","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1212\/WNL.0000000000002355","article-title":"What the ancient Greeks and Romans knew (and did not know) about seasickness","volume":"86","author":"Huppert","year":"2016","journal-title":"Neurology"},{"key":"B158","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0140-6736(02)38129-7","article-title":"The pathology of sea-sickness","volume":"118","author":"Irwin","year":"1881","journal-title":"Lancet"},{"key":"B159","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/S0140-6736(54)90352-9","article-title":"Influence of chlorpromazine and promethaziane on vomiting induced by apomorphine in man","volume":"267","author":"Isaacs","year":"1954","journal-title":"Lancet"},{"key":"B160","first-page":"637","article-title":"Neurotransmitter receptor binding studies predict antiemetic efficacy and side effects","volume":"70","author":"Ison","year":"1986","journal-title":"Cancer Treat. Rep."},{"key":"B161","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0016-5085(67)80129-X","article-title":"Gastrointestinal actions of metoclopramide. An experimental study","volume":"52","author":"Jacoby","year":"1967","journal-title":"Gastroenterol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/ajg.2013.118","article-title":"The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis","volume":"108","author":"Janssen","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejphar.2012.11.035","article-title":"Anti-emetic and emetic effects of erythromycin in Suncus murinus: potential role of vagal activation, increased gastric motility and motilin receptors","volume":"699","author":"Javid","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejphar.2013.10.014","article-title":"Looking beyond 5-HT3 receptors: a review of the wider role of serotonin in the pharmacology of nausea and vomiting","volume":"722","author":"Johnston","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1089\/jpm.2011.0058","article-title":"Antiemetics for chemotherapy-induced nausea and vomiting occurring despite prophylactic antiemetic therapy","volume":"14","author":"Jones","year":"2011","journal-title":"J. Palliat. Med."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s00520-015-2990-4","article-title":"Defining the efficacy of neurokinin-1 receptor antagonists in controlling chemotherapy-induced nausea and vomiting in different emetogenic settings\u2014a meta-analysis","volume":"24","author":"Jordan","year":"2016","journal-title":"Support Care Cancer"},{"key":"B167","first-page":"723","article-title":"Action anti\u00e9m\u00e9tique du m\u00e9toclopramide vis-\u00e0-vis de l'apomorphine et de l'hydergine","volume":"158","author":"Justin-Besancon","year":"1964","journal-title":"C. R. Seances Soc. Biol. Fil."},{"key":"B168","first-page":"4384","article-title":"Le M\u00e9toclopramide et ses homologues. Introduction \u00e0 leur \u00e9tude biologique","volume":"258","author":"Justin-Besancon","year":"1964","journal-title":"C. R. Acad. Sci."},{"key":"B169","author":"Kail","year":"1986","journal-title":"The Medical Mind of Shakespeare"},{"key":"B170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(84)90856-4","article-title":"Histamine H1 receptors in human brain labelled with [3H]doxepin","volume":"304","author":"Kanba","year":"1984","journal-title":"Brain Res."},{"key":"B171","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1007\/s40265-015-0512-9","article-title":"Netupitant\/Palonsetron: a review in the prevention of chemotherapy-induced nausea and vomiting","volume":"75","author":"Keating","year":"2015","journal-title":"Drugs"},{"key":"B172","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/277093a0","article-title":"Multiple receptors for dopamine","volume":"277","author":"Kebabian","year":"1979","journal-title":"Nature"},{"key":"B173","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature08506","article-title":"Predicting new molecular targets for known drugs","volume":"462","author":"Keiser","year":"2009","journal-title":"Nature"},{"key":"B174","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0960-894X(99)00591-0","article-title":"New 2-substituted 1,2,3,4-tetrahydrobenzofuro[3,2-c] pyridine having highly active and potent central alpha 2-antagonistic activity as potential antidepressants","volume":"10","author":"Kennis","year":"2000","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"B175","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12917-017-1156-7","article-title":"Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study","volume":"13","author":"Kenward","year":"2017","journal-title":"BMC Vet. Res"},{"key":"B176","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1176\/appi.psy.47.5.440","article-title":"Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment","volume":"47","author":"Kim","year":"2006","journal-title":"Psychosomatics"},{"key":"B177","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neulet.2004.11.015","article-title":"Effect of a selective and potent central nervous system penetrant, neurokinin-3 receptor antagonist (SB-222200), on cisplatin-induced emesis in the ferret","volume":"376","author":"King","year":"2005","journal-title":"Neurosci. Lett."},{"key":"B178","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/oxfordjournals.annonc.a058558","article-title":"Early clinical trial of MDL 73.147 EF: a new 5-HT3-receptors antagonist for the prevention of chemotherapy-induced nausea and vomiting","volume":"4","author":"Kirchner","year":"1993","journal-title":"Ann. Oncol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1007\/s00221-014-4007-9","article-title":"Gastric dysrhythmias: a potential objective measure of nausea","volume":"232","author":"Koch","year":"2014","journal-title":"Exp. Brain Res."},{"key":"B180","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-34076-0","volume-title":"Nausea and Vomiting. Diagnosis and Treatment","author":"Koch","year":"2017"},{"key":"B181","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"B182","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1126\/science.281.5383.1640","article-title":"Distinct mechanism for antidepressant activity by blockade of central substance P receptors","volume":"281","author":"Kramer","year":"1998","journal-title":"Science"},{"key":"B183","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/bja\/aet251","article-title":"I.V. APD421 (amisulpride) prevents postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled, multicentre trial","volume":"111","author":"Kranke","year":"2013","journal-title":"Br. J. Anaesth"},{"key":"B184","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/jnci\/89.11.817","article-title":"Control of emesis following cisplatin by CP-122,721, a selective NK1 receptor antagonist","volume":"89","author":"Kris","year":"1997","journal-title":"J. Natl. Cancer Inst"},{"key":"B185","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/sj.npp.1300027","article-title":"H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs","volume":"28","author":"Kroeze","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"B186","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1254\/jjp.43.277","article-title":"Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay","volume":"43","author":"Kubo","year":"1987","journal-title":"Jpn. J. Pharmacol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"6671","DOI":"10.3748\/wjg.v20.i21.6671","article-title":"Rapid improvement in post-infectious gastroparesis symptoms with mirtazapine","volume":"20","author":"Kundu","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1007\/s00221-014-4008-8","article-title":"Motion sickness: more than nausea and vomiting","volume":"232","author":"Lackner","year":"2014","journal-title":"Exp. Brain Res"},{"key":"B189","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0306-4522(00)00148-2","article-title":"Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene","volume":"98","author":"Laird","year":"2000","journal-title":"Neuroscience"},{"key":"B190","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1600-0447.1993.tb03391.x","article-title":"Levomepromazine receptor binding profile in human brain\u2013implications for treatment-resistant schizophrenia","volume":"87","author":"Lal","year":"1993","journal-title":"Acta Psychiatr. Scand."},{"key":"B191","doi-asserted-by":"publisher","first-page":"321","DOI":"10.5056\/jnm15141","article-title":"The role of central and enteric nervous systems in the control of the retrograde giant contraction","volume":"22","author":"Lang","year":"2016","journal-title":"J. Neurogastroenterol. Motil"},{"key":"B192","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ejphar.2004.11.019","article-title":"Action of ondansetron and CP-99,994 to modify behavior and antagonize cisplatin-induced emesis in the ferret","volume":"506","author":"Lau","year":"","journal-title":"Eur. J. Pharmacol"},{"key":"B193","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ejphar.2005.05.028","article-title":"Differential action of domperidone to modify emesis and behaviour induced by apomorphine in the ferret","volume":"516","author":"Lau","year":"","journal-title":"Eur. J. Pharmacol."},{"key":"B194","volume-title":"Adverse Drug Reactions","author":"Lee","year":"2006"},{"key":"B195","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fphys.2011.00029","article-title":"Biophysically based modelling of the interstitial cells of Cajal: current status and future perspectives","volume":"2","author":"Lees-Green","year":"2011","journal-title":"Front. Physiol."},{"key":"B196","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.pharmthera.2016.06.007","article-title":"Current drug treatments targeting dopamine D3 receptor","volume":"165","author":"Leggio","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"B197","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1053\/j.gastro.2016.03.038","article-title":"Relamorelin reduces vomiting frequency and severity and accelerates gastric emptying in adults with diabetic gastroparesis","volume":"151","author":"Lembo","year":"2016","journal-title":"Gastroenterology"},{"key":"B198","doi-asserted-by":"publisher","first-page":"S158","DOI":"10.1016\/S0016-5085(14)60565-5","article-title":"A phase 2, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of RM-131 in patients with diabetic gastroparesis","volume":"146","author":"Lembo","year":"2014","journal-title":"Gastroenterology"},{"key":"B199","first-page":"316","article-title":"Motion sickness susceptibility and related behavioral characteristics in men and women","volume":"48","author":"Lentz","year":"1977","journal-title":"Aviat. Space Environ. Med"},{"key":"B200","volume-title":"Pain","author":"Lewis","year":"1942"},{"key":"B201","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/j.1476-5381.2012.02066.x","article-title":"The anti-nausea effects of CB1 agonists are mediated by an action at the visceral insular cortex","volume":"167","author":"Limebeer","year":"2012","journal-title":"Br. J. Pharmacol"},{"key":"B202","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s11373-005-9053-7","article-title":"Anti-muscarinic actions of antihistamines on the heart","volume":"13","author":"Liu","year":"2006","journal-title":"J. Biomed. Sci."},{"key":"B203","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/10401230591002002","article-title":"History of the discovery and clinical introduction of chlorpromazine","volume":"17","author":"L\u00f3pez-Mu\u00f1oz","year":"2005","journal-title":"Ann. Clin. Psych."},{"key":"B204","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.npep.2017.04.006","article-title":"Centrally located GLP-1 receptors modulate gastric slow waves and cardiovascular function in ferrets consistent with the induction of nausea","volume":"65","author":"Lu","year":"","journal-title":"Neuropeptides"},{"key":"B205","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.autneu.2016.09.003","article-title":"Insights into the central pathways involved in the emetic and behavioural responses to exendin-4 in the ferret","volume":"202","author":"Lu","year":"","journal-title":"Auton. Neurosci."},{"key":"B206","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1748-1716.1978.tb06307.x","article-title":"Peptide neurons in the vagus, splanchnic and sciatic nerves","volume":"104","author":"Lundberg","year":"1978","journal-title":"Acta. Physiol. Scand."},{"key":"B207","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3978\/j.issn.2224-5820.2012.07.11","article-title":"Medication related nausea and vomiting in palliative medicine","volume":"1","author":"Maceira","year":"2012","journal-title":"Ann. Palliat. Med."},{"key":"B208","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1089\/jpm.2015.0224","article-title":"Olanzapine in the management of difficult to control nausea and vomiting in a palliative care population: a case series","volume":"19","author":"MacIntosh","year":"2016","journal-title":"J. Palliat. Med."},{"key":"B209","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0165-6147(00)01463-2","article-title":"The troubled story of tachykinins and neurokinins","volume":"21","author":"Maggi","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"B210","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11845-011-0785-2","article-title":"Does domperidone, a D2-antagonist alter gastric emptying rates and appetite sensations in healthy adults with high-fat meal? A block-randomised, single-blind placebo-controlled study","volume":"181","author":"Markey","year":"2012","journal-title":"Ir. J. Med. Sci."},{"key":"B211","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/mds.27259","article-title":"A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's disease","volume":"33","author":"Marrinan","year":"2018","journal-title":"Mov. Disord."},{"key":"B212","first-page":"410","article-title":"Seasickness other forms of motion sickness","volume":"2","author":"McEachern","year":"1942","journal-title":"War Med."},{"key":"B213","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00228-017-2399-8","article-title":"Domperidone prolongs oral to duodenal transit time in video capsule endoscopy","volume":"74","author":"McFarlane","year":"2018","journal-title":"Eur. J. Clin. Pharmacol"},{"key":"B214","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0022-3565(25)39332-8","article-title":"Pharmacology of CP-99, 994; a non-peptide antagonist of the tachykinin neurokinin-1 receptor","volume":"267","author":"McLean","year":"1993","journal-title":"J. Pharamcol. Exp. Ther"},{"key":"B215","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4684-4853-5_20","article-title":"Dopamine antagonists as anti-emetics and as stimulants of gastric motility","volume-title":"Mechanisms of Gastrointestinal Motility & Secretion","author":"McRitchie","year":"1984"},{"key":"B216","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/acem.12685","article-title":"Measurement and monitoring of nausea severity in emergency department patients: a comparison of scales and exploration of treatment efficacy outcome measures","volume":"22","author":"Meek","year":"2015","journal-title":"Acad. Emerg. Med."},{"key":"B217","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-3565(25)20710-8","article-title":"Classification of typical and atypical antipsychotic drugs on the basis of dopamine, D-2 and serotonin2 pKi values","volume":"251","author":"Meltzer","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B218","doi-asserted-by":"publisher","first-page":"650","DOI":"10.5056\/jnm15203","article-title":"Granisetron transdermal system for treatment of symptoms of gastroparesis: a prescription registry study","volume":"22","author":"Midani","year":"2016","journal-title":"J. Neurogastroenterol. Motil."},{"key":"B219","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1124\/jpet.102.039867","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes","volume":"303","author":"Millan","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B220","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1749-6632.1996.tb15755.x","article-title":"Human cortical activity during vestibular- and drug-induced nausea detected using MSI","volume":"781","author":"Miller","year":"1996","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"B221","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0014-2999(01)01297-3","article-title":"Effects of CP-99, 994, a tachykinin NK1 receptor antagonist, on abdominal afferent vagal activity in ferrets: evidence for involvement of NK1 and 5-HT3 receptors","volume":"428","author":"Minami","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1476-5381.1986.tb10228.x","article-title":"Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism","volume":"88","author":"Miner","year":"1986","journal-title":"Br. J. Pharmacol."},{"key":"B223","first-page":"374P","article-title":"Comparison of the effect of BRL 24924, metoclopramide and domperidone on cis-platin-induced emesis in the ferret","volume":"88","author":"Miner","year":"1986","journal-title":"Br. J. Pharmacol."},{"key":"B224","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/bjc.1987.177","article-title":"Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis","volume":"56","author":"Miner","year":"1987","journal-title":"Br. J. Cancer"},{"key":"B225","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/clpt.1993.109","article-title":"Ipecacuanha-induced emesis: a human model for testing antiemetic drug activity","volume":"54","author":"Minton","year":"1993","journal-title":"Clin. Pharmacol. Ther."},{"key":"B226","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0016-5085(19)33898-3","article-title":"Controlled clinical studies of orally administered antiemetic drugs","volume":"57","author":"Moertel","year":"1969","journal-title":"Gastroenterology"},{"key":"B227","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.1970.50.1.1","article-title":"Motion sickness","volume":"50","author":"Money","year":"1970","journal-title":"Physiol. Rev"},{"key":"B228","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.bcp.2004.05.019","article-title":"Comparative pharmacology of human D2-like receptor stable cell lines coupled to calcium flux through G\u03b1qo5","volume":"68","author":"Moreland","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"B229","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1001\/archinte.1955.00250080024004","article-title":"Chlorpromazine as a therapeutic agent in clinical medicine","volume":"95","author":"Moyer","year":"1955","journal-title":"AMA Arch. Intern. Med."},{"key":"B230","first-page":"21","article-title":"Management of postoperative nausea and vomiting: focus on palonosetron","volume":"5","author":"Muchatuta","year":"2009","journal-title":"Ther. Clin. Risk Manag."},{"key":"B231","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/cercor\/bhs073","article-title":"The brain circuitry underlying the temporal evolution of nausea in humans","volume":"23","author":"Napadow","year":"2012","journal-title":"Cereb. Cortex"},{"key":"B232","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejphar.2013.08.048","article-title":"Olanzapine for the prevention and treatment of chronic nausea and chemotherapy-induced nausea and vomiting","volume":"722","author":"Navari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B233","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1056\/NEJM199901213400304","article-title":"Reduction of cisplatin-induced emesis by a selective neurokinin-1 receptor antagonist L-754,030","volume":"340","author":"Navari","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"B234","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/cne.902340107","article-title":"The distribution of substance P, encephalin, and serotonin immunoreactivities in the area postrema of the rat and cat","volume":"234","author":"Newton","year":"1985","journal-title":"J. Comp. Neurol"},{"key":"B235","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1634\/theoncologist.2014-0438","article-title":"Chemotherapy-induced nausea and vomiting: time for more emphasis on nausea?","volume":"20","author":"Ng","year":"2014","journal-title":"Oncologist"},{"key":"B236","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1139\/cjr45e-023","article-title":"Observations on various types of motion causing vomiting in animals","volume":"23","author":"Noble","year":"1945","journal-title":"Can. J. Res."},{"key":"B237","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0022-3565(25)11389-X","article-title":"Pharmacologic properties of cyclizine hydrochloride (marezine)","volume":"112","author":"Norton","year":"1954","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B238","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1053\/j.gastro.2012.05.036","article-title":"Abnormal initiation and conduction of slow-wave activity in gastroparesis, defined by high-resolution electrical mapping","volume":"143","author":"O'Grady","year":"2012","journal-title":"Gastroenterology"},{"key":"B239","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3233\/VES-2011-0432","article-title":"Are evolutionary hypotheses for motion sickness \u201cjust-so\u201d stories?","volume":"22","author":"Oman","year":"2012","journal-title":"J. Vestib. Res."},{"key":"B240","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/MAJ.0000000000000439","article-title":"Cardiovascular safety profile and clinical experience with high-dose domperidone therapy for nausea and vomiting","volume":"349","author":"Ortiz","year":"2015","journal-title":"Am. J. Med. Sci."},{"key":"B241","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0022-3565(24)37161-7","article-title":"Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites","volume":"283","author":"Owens","year":"1997","journal-title":"J. Pharmaol. Exp. Ther."},{"key":"B242","doi-asserted-by":"publisher","first-page":"G6","DOI":"10.1152\/ajpgi.00095.2002","article-title":"Physiology and pathophysiology of the interstitial cells of Cajal: from bench to bedside. Vl. Pathogenesis and therapeutic approaches to human gastric dysrhythmias","volume":"283","author":"Owyang","year":"2002","journal-title":"Am. J. Physiol."},{"key":"B243","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF03015417","article-title":"Anaesthesia and emesis. II. Prevention and management","volume":"31","author":"Palazzo","year":"1984","journal-title":"Can. Anaesth. Soc. J."},{"key":"B244","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1111\/j.1476-5381.2010.01176.x","article-title":"Regulation of nausea and vomiting by cannabinoids","volume":"163","author":"Parker","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B245","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/toxsci\/kfr334","article-title":"Application of data mining and visualisation techniques for the prediction of drug-induced nausea in man","volume":"126","author":"Parkinson","year":"2012","journal-title":"Toxicol. Sci."},{"key":"B246","doi-asserted-by":"publisher","first-page":"S480","DOI":"10.1053\/j.gastro.2017.08.033","article-title":"Aprepitant for symptoms of gastroparesis and related disorders: the APRON randomized clinical trial","volume":"111","author":"Pasricha","year":"2016","journal-title":"Am. J. Gastroenterol"},{"key":"B247","doi-asserted-by":"publisher","first-page":"G470","DOI":"10.1152\/ajpgi.1989.257.3.G470","article-title":"Erythromycin is a motilin receptor agonist","volume":"257","author":"Peeters","year":"1989","journal-title":"Am. J. Physiol."},{"key":"B248","doi-asserted-by":"publisher","first-page":"11S","DOI":"10.1002\/j.1552-4604.1981.tb02568.x","article-title":"Clinical trials with antiemetic agents in cancer patients receiving chemotherapy","volume":"21","author":"Penta","year":"1981","journal-title":"J. Clin. Pharmacol"},{"key":"B249","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/9781118782699.ch31","article-title":"The ferret in nausea and vomiting research: lessons in translation of basic science to the clinic","volume-title":"Biology and Diseases of the Ferret","author":"Percie du Sert","year":"2014"},{"key":"B250","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1111\/j.1476-5381.2011.01669.x","article-title":"Predicting the emetic liability of novel chemical entities: a comparative study","volume":"165","author":"Percie du Sert","year":"2012","journal-title":"Br. J. Pharmacol"},{"key":"B251","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S0140-6736(82)92206-1","article-title":"Antiemetics: neurotransmitter receptor binding predicts therapeutic actions","volume":"2","author":"Peroutka","year":"1982","journal-title":"Lancet"},{"key":"B252","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1176\/ajp.137.12.1518","article-title":"Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency","volume":"137","author":"Peroutka","year":"1980","journal-title":"Am. J. Psychiatry"},{"key":"B253","first-page":"2949","article-title":"Ultrastructural localization of monoamines and peptides in rat area postrema","volume":"43","author":"Pickel","year":"1984","journal-title":"Fed. Proc"},{"key":"B254","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2165\/00003495-197612020-00001","article-title":"Metoclopramide: a review of its pharmacological properties and clinical use","volume":"12","author":"Pinder","year":"1976","journal-title":"Drugs"},{"key":"B255","first-page":"1493","article-title":"Immediate termination of intractable vomiting induced by cisplatin combination chemotherapy using an intensive five drug regimen","volume":"68","author":"Plezia","year":"1984","journal-title":"Cancer Treat. Res."},{"key":"B256","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1023\/A:1018878324327","article-title":"Tricyclic antidepressants for functional nausea and vomiting: clinical outcome in 37 patients","volume":"43","author":"Prakash","year":"1998","journal-title":"Dig. Dis. Sci."},{"key":"B257","first-page":"177","article-title":"The evolution of pregnancy sickness as protection to the embryo against Pleistocene teratogens","volume":"8","author":"Profet","year":"1988","journal-title":"Evol. Theory"},{"key":"B258","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/oso\/9780195060232.003.0009","article-title":"Pregnancy sickness as adaptation: a deterrent to maternal ingestion of teratogens","volume-title":"The Adapted Mind","author":"Profet","year":"1992"},{"key":"B259","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/014107687807101109","article-title":"Motion sickness adaptation: a neural mismatch model","volume":"71","author":"Reason","year":"1978","journal-title":"J. R. Soc. Med."},{"key":"B260","volume-title":"Motion Sickness","author":"Reason","year":"1975"},{"key":"B261","first-page":"1148","article-title":"Genetic influences on motion sickness susceptibility in adult women: a classical twin study","volume":"77","author":"Reavley","year":"2006","journal-title":"Aviat. Space Environ. Med."},{"key":"B262","first-page":"168","article-title":"Comparison of neurokinin-1 antagonist, L-745,030, to placebo, acetaminophen and ibuprofen in the dental pain model","volume":"63","author":"Reinhardt","year":"1998","journal-title":"Clin. Pharmacol.Ther"},{"key":"B263","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1001\/jama.282.18.1766","article-title":"Fair conduct and fair reporting of clinical trials","volume":"282","author":"Rennie","year":"1999","journal-title":"JAMA"},{"key":"B264","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1365-2036.2009.04078.x","article-title":"Development and content validity of a gastroparesis cardinal symptom index daily diary","volume":"30","author":"Revicki","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B265","doi-asserted-by":"publisher","first-page":"6105","DOI":"10.1113\/jphysiol.2011.217497","article-title":"Analysis of pacemaker activity in the human stomach","volume":"589","author":"Rhee","year":"2011","journal-title":"J. Physiol."},{"key":"B266","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0090-8258(80)90027-X","article-title":"Methylprednisolone as an antiemetic during cancer chemotherapy\u2013a pilot study","volume":"9","author":"Rich","year":"1980","journal-title":"Gynecol. Oncol."},{"key":"B267","volume-title":"Rang and Dale's Pharmacology","author":"Ritter","year":"2016"},{"key":"B268","first-page":"9","article-title":"Metoclopramide\u2013a new pharmacological approach?","volume":"49","author":"Robinson","year":"1973","journal-title":"Postgrad. Med. J."},{"key":"B269","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fphar.2016.00221","article-title":"Cannabinoids as potential treatment for chemotherapy-induced nausea and vomiting","volume":"7","author":"Rock","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B270","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejphar.2013.08.049","article-title":"Molecular mechanisms of 5-HT3 and NK1 receptor antagonists in prevention of emesis","volume":"722","author":"Rojas","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B271","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2012.01.046","article-title":"Pharmacological mechanisms of 5-HT3 and tachykinin NK1 receptor antagonism to prevent chemotherapy-induced nausea and vomiting","volume":"684","author":"Rojas","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"B272","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ejphar.2009.10.002","article-title":"Palonosetron triggers 5-HT3 receptor internalization and causes prolonged inhibition of receptor function","volume":"626","author":"Rojas","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"B273","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0006-8993(82)90214-1","article-title":"Differential affinities of molindone, metoclopramide and domperidone for classes of [3H]spiroperidol binding sites in rat striatum: evidence for pharmacologically distinct classes of receptors","volume":"235","author":"Rosenfeld","year":"1982","journal-title":"Brain Res."},{"key":"B274","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0165-6147(99)01396-6","article-title":"Discovery of the anti-depressant and anti-emetic efficacy of substance P receptor (NK1) antagonists","volume":"20","author":"Rupniak","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"B275","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJM197510162931603","article-title":"Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy","volume":"293","author":"Sallen","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"B276","first-page":"1301","article-title":"Comparison of the antiemetic efficacy of two high-dose benzamides, metoclopramide and alizapride, against cisplatin-induced emesis","volume":"69","author":"Saller","year":"1985","journal-title":"Cancer Treat. Rep."},{"key":"B277","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0014-2999(03)01863-6","article-title":"Action of 5-HT3 receptor antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew)","volume":"472","author":"Sam","year":"2003","journal-title":"Eur. J. Pharmacol"},{"key":"B278","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.2042-7158.1985.tb05108.x","article-title":"Effects of metoclopramide and domperidone on cholinergically-mediated contractions of human isolated stomach muscle","volume":"37","author":"Sanger","year":"","journal-title":"J. Pharm. Pharmacol."},{"key":"B279","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0014-2999(85)90621-1","article-title":"The effects of various pharmacological agents on the metoclopramide-induced increase in cholinergic-mediated contractions of rat isolated forestomach","volume":"114","author":"Sanger","year":"","journal-title":"Eur. J. Pharmacol."},{"key":"B280","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.2042-7158.1985.tb03076.x","article-title":"Three different ways in which 5-hydroxytryptamine can affect cholinergic activity in guinea-pig isolated ileum","volume":"37","author":"Sanger","year":"","journal-title":"J. Pharm. Pharmacol."},{"key":"B281","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.2042-7158.1987.tb03418.x","article-title":"Activation by metoclopramide of a myenteric 5-hydroxytryptamine-like receptor","volume":"39","author":"Sanger","year":"","journal-title":"J. Pharm. Pharmacol."},{"key":"B282","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1476-5381.1987.tb08985.x","article-title":"Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924","volume":"91","author":"Sanger","year":"","journal-title":"Br. J. Pharmacol."},{"key":"B283","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1139\/y90-046","article-title":"New anti-emetic drugs","volume":"68","author":"Sanger","year":"1990","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B284","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/sj.bjp.0705742","article-title":"Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain","volume":"141","author":"Sanger","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"B285","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/j.1365-2982.2009.01425.x","article-title":"Translating 5-HT4 receptor pharmacology","volume":"21","author":"Sanger","year":"2009","journal-title":"Neurogastroenterol. Motil."},{"key":"B286","first-page":"1031","article-title":"Metoclopramide: a template for drug discovery","volume":"4","author":"Sanger","year":"2017","journal-title":"J. Drug. Des. Res"},{"key":"B287","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2982.2008.01084.x","article-title":"Development of drugs for gastrointestinal motor disorders: translating science to clinical need","volume":"20","author":"Sanger","year":"2008","journal-title":"Neurogastroenterol. Motil"},{"key":"B288","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.autneu.2006.07.009","article-title":"Treatment of nausea and vomiting: gaps in our knowledge","volume":"129","author":"Sanger","year":"2006","journal-title":"Auton. Neurosci."},{"key":"B289","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejphar.2013.06.031","article-title":"The relationship between gastric motility and nausea: gastric prokinetic agents as treatments","volume":"715","author":"Sanger","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"B290","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrgastro.2015.163","article-title":"Ghrelin and motilin receptors as drug targets for gastrointestinal disorders","volume":"13","author":"Sanger","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B291","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.tips.2011.03.009","article-title":"The translational value of rodent gastrointestinal functions: a cautionary tale","volume":"32","author":"Sanger","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"B292","first-page":"273","article-title":"From metoclopramide to selective gut motility stimulants and 5-HT3 receptor antagonists","volume":"3","author":"Sanger","year":"1988","journal-title":"Drug Des. Deliv."},{"key":"B293","first-page":"1262","article-title":"Novel Treatment. US Patent 4725603, February 16, 1988","volume":"1087","author":"Sanger","year":"1988","journal-title":"Off. Gazet. US Pat. Trademark Off. Pat."},{"key":"B294","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/13543784.2017.1288214","article-title":"Investigational drug therapies for the treatment of gastroparesis","volume":"26","author":"Sanger","year":"2017","journal-title":"Exp. Opin. Invest. Drugs"},{"key":"B295","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0014-2999(99)00259-9","article-title":"The tachykinin NK1 receptor in the brain: pharmacology and putative functions","volume":"375","author":"Saria","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"B296","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s10620-006-9378-8","article-title":"Tricyclic antidepressants for chronic vomiting in diabetic patients","volume":"52","author":"Sawhney","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"B297","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3181\/00379727-82-20141","article-title":"Effect of dimenhydrinate and diphenhydramine on apomorphine-induced emesis in dogs and cats","volume":"82","author":"Schmidt","year":"1953","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"B298","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0016-5085(79)90236-1","article-title":"Metoclopramide","volume":"77","author":"Schulze-Delrieu","year":"1979","journal-title":"Gastroenterol."},{"key":"B299","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-1-4613-2837-7_16","article-title":"Evaluation of platinum complexes for emetic potential","volume-title":"Platinum Coordination Complexes in Cancer","author":"Schurig","year":"1984"},{"key":"B300","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/cercor\/bhu172","article-title":"Brain circuitry supporting multi-organ autonomic outflow in response to nausea","volume":"26","author":"Sclocco","year":"2016","journal-title":"Cereb. Cortex"},{"key":"B301","first-page":"2011","article-title":"Activit\u00e9 d'une nouvelle phenothiazine en psychiatrie et en neurologie","volume":"87","author":"Sigwald","year":"1956","journal-title":"Presse M\u00e9d."},{"key":"B302","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1097\/00000542-200105000-00029","article-title":"The cannabinoid agonist WIN55,212-2 suppresses opioid-induced emesis in ferrets","volume":"94","author":"Simoneau","year":"2001","journal-title":"Anesthesiology"},{"key":"B303","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/WOX.0b013e318186fb3a","article-title":"H1 antihistamines: current status and future directions","volume":"1","author":"Simons","year":"2011","journal-title":"World Allergy Organ J"},{"key":"B304","doi-asserted-by":"publisher","first-page":"508","DOI":"10.4065\/mcp.2010.0267","article-title":"New uses for older drugs: the tales of aspirin, thalidomide, and gabapentin","volume":"85","author":"Sirven","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"B305","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2165\/00003495-199957010-00004","article-title":"Second-generation antihistamines: a comparative review","volume":"57","author":"Slater","year":"1999","journal-title":"Drugs"},{"key":"B306","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejphar.2013.09.074","article-title":"Opioid induced nausea and vomiting","volume":"722","author":"Smith","year":"2014","journal-title":"Eur. J. Pharmacol"},{"key":"B307","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00210-008-0282-y","article-title":"The in vitro pharmacological profile of TD-5108, a selective 5-HT4 receptor agonist with high intrinsic activity","volume":"378","author":"Smith","year":"2008","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B308","doi-asserted-by":"crossref","DOI":"10.1002\/0470015535","volume-title":"Drug Discovery. A History.","author":"Sneader","year":"2005"},{"key":"B309","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1126\/science.1703323","article-title":"A potent nonpeptide antagonist of the substance P (NK1) receptor","volume":"251","author":"Snider","year":"1991","journal-title":"Science"},{"key":"B310","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1126\/science.184.4143.1243","article-title":"Drugs, neurotransmitters and schizophrenia","volume":"184","author":"Snyder","year":"1974","journal-title":"Science"},{"key":"B311","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/j.pain.2014.06.011","article-title":"Biased agonism of the \u03bc-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: a randomized double-blind, placebo controlled, crossover study in healthy volunteers","volume":"155","author":"Soergel","year":"2014","journal-title":"Pain"},{"key":"B312","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/157015910790909511","article-title":"Neuropharmacology of vestibular system disorders","volume":"8","author":"Soto","year":"2010","journal-title":"Curr. Neuropharmacol"},{"key":"B313","first-page":"S15","article-title":"A comparison of two dose levels of granisetron in patients receiving high-dose cisplatin","volume":"26","author":"Soukop","year":"1990","journal-title":"Eur. J. Cancer"},{"key":"B314","doi-asserted-by":"publisher","first-page":"CD002851","DOI":"10.1002\/14651858.CD002851.pub4","article-title":"Scopolamine (hyoscine) for preventing and treating motion sickness","volume":"6","author":"Spinks","year":"2011","journal-title":"Cochrane Database Syst. Rev"},{"key":"B315","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4321\/S0213-61632009000300003","article-title":"Binding of levomepromazine and cyamemazine to human recombinant dopamine receptor subtypes","volume":"23","author":"Srivastava","year":"2009","journal-title":"Eur. J. Psychiatry"},{"key":"B316","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/00000542-200301000-00011","article-title":"Difference in risk factors for postoperative nausea and vomiting","volume":"98","author":"Stadler","year":"2003","journal-title":"Anaesthesiology"},{"key":"B317","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0014-2999(81)90540-9","article-title":"Detection of dopamine receptors in the area postrema","volume":"74","author":"Stefanini","year":"1981","journal-title":"Eur. J. Pharmacol."},{"key":"B318","first-page":"827","article-title":"Chinese hyper-susceptibility to vection-induced motion sickness","volume":"64","author":"Stern","year":"1983","journal-title":"Aviat. Space Environ. Med."},{"key":"B319","volume-title":"Nausea: Mechanisms and Management.","author":"Stern","year":"2011"},{"key":"B320","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/0091270004264641","article-title":"Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptamine-3 receptor antagonist, in U.S. and Japanese healthy subjects","volume":"44","author":"Stoltz","year":"2004","journal-title":"J. Clin. Pharmacol."},{"key":"B321","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1007\/s00221014-3987-9","article-title":"Association of mu-opioid receptor gene (OPRM1) haplotypes with postoperative nausea and vomiting","volume":"232","author":"Sugino","year":"2014","journal-title":"Exp. Brain Res"},{"key":"B322","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1254\/jjp.33.557","article-title":"Effects of diphenhydrmaine iontophoretically applied onto neurons in the medial and lateral vestibular nuclei","volume":"33","author":"Takatani","year":"1983","journal-title":"Jpn. J. Pharmacol"},{"key":"B323","doi-asserted-by":"publisher","first-page":"R5","DOI":"10.1016\/0014-2999(93)90649-3","article-title":"The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret","volume":"250","author":"Tattersall","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"B324","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0028-3908(94)90018-3","article-title":"Enantioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994","volume":"33","author":"Tattersall","year":"1994","journal-title":"Neuropharmacology"},{"key":"B325","first-page":"257","article-title":"The history of hyoscine","volume":"17","author":"Thearle","year":"1982","journal-title":"Hist. Sci. Med."},{"key":"B326","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/0277-5379(85)90219-6","article-title":"A pilot study of high dose domperidone as an anti-emetic in patients treated with cisplatin","volume":"21","author":"Tonato","year":"1985","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"B327","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1200\/JCO.2003.05.164","article-title":"Variations in the 5-hydroxytryptamine type 3B receptor gene as predicters of the efficacy of antiemetic treatment in cancer patients","volume":"21","author":"Tremblay","year":"2003","journal-title":"J. Clin. Oncol"},{"key":"B328","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2133\/dmpk.DMPK-12-RG-084","article-title":"Association of ABCB1 polymorphisms with the antiemetic efficacy of granisetron plus dexamethasone in breast cancer patients","volume":"28","author":"Tsuji","year":"2013","journal-title":"Drug Metab. Pharmacokinet"},{"key":"B329","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fphys.2017.00412","article-title":"Brain activation by H1 antihistmaines challenges conventional view of their mechanism of action in motion sickness: a behavioural c-fos and physiological study in Suncus murinus (house musk shrew)","volume":"8","author":"Tu","year":"2017","journal-title":"Front. Physiol."},{"key":"B330","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/0024-3205(87)90229-3","article-title":"Suncus murinus: a new experimental model in emesis research","volume":"41","author":"Ueno","year":"1987","journal-title":"Life Sci."},{"key":"B331","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/0024-3205(88)90520-6","article-title":"Suncus murinus as a new experimental model for motion sickness","volume":"43","author":"Ueno","year":"1988","journal-title":"Life Sci."},{"key":"B332","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1476-5829.2006.00123.x","article-title":"Efficacy of injectable maropitant (Cerenia\u2122) in a randomized clinical trial for prevention and treatment of cisplatin-induced emesis in dogs presented as veterinary patients","volume":"5","author":"Vail","year":"2007","journal-title":"Vet. Comp. Oncol."},{"key":"B333","doi-asserted-by":"publisher","first-page":"G566","DOI":"10.1152\/ajpgi.00113.2003","article-title":"Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets","volume":"285","author":"Van Sickle","year":"2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol"},{"key":"B334","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2165\/00003495-198300251-00006","article-title":"Review of cannabinoids and their antiemetic effectiveness","volume":"25","author":"Vincent","year":"1983","journal-title":"Drugs"},{"key":"B335","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF01960436","article-title":"Untersuchungen \u00fcber Substanz P, die atropinfeste, darmerregende und gef\u00e4sserweiternde Substanz aus Darm und Gehirn","volume":"181","author":"von Euler","year":"1936","journal-title":"Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol."},{"key":"B336","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1113\/jphysiol.1931.sp002763","article-title":"An unidentified depressor substance in certain tissue extracts","volume":"72","author":"von Euler","year":"1931","journal-title":"J. Physiol. (Lond)"},{"key":"B337","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2165\/00003495-198300251-00005","article-title":"The pharmacology and clinical effectiveness of phenothiazines and related drugs for managing chemotherapy-induced emesis","volume":"25","author":"Wampler","year":"1983","journal-title":"Drugs"},{"key":"B338","first-page":"255","article-title":"Emetic and anti-emetic drugs","volume-title":"Physiological Pharmacology, Volume II, The Nervous System Part B","author":"Wang","year":"1965"},{"key":"B339","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1001\/archneurpsyc.1950.02310240087005","article-title":"The vomiting center. A critical experimental analysis","volume":"63","author":"Wang","year":"1950","journal-title":"AMA Arch. Neurol. Psychiat"},{"key":"B340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0016-5085(19)36357-7","article-title":"A new concept of organization of the central emetic mechanism: recent studies on the sites of action of apomorphine, copper sulphate and cardiac glycosides","volume":"22","author":"Wang","year":"1952","journal-title":"Gastroenterology"},{"key":"B341","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ejphar.2013.10.015","article-title":"Prognostic factors for chemotherapy induced nausea and vomiting","volume":"722","author":"Warr","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B342","first-page":"23","article-title":"Controlling nausea and vomiting in patients undergoing chemotherapy. Toward more effective clinical practice","volume":"8","author":"Warr","year":"2009","journal-title":"Oncol. Exchange"},{"key":"B343","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1476-5381.1995.tb16324.x","article-title":"The anti-emetic effects of CP-99,994 in the ferret and the dog: role of NK1 receptors","volume":"115","author":"Watson","year":"","journal-title":"Br. J. Pharmacol"},{"key":"B344","first-page":"233","article-title":"Tachykinins and emesis: towards complete control?","volume-title":"Serotonin and Emesis: A Decade of Progress?","author":"Watson","year":""},{"key":"B345","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1152\/japplphysiol.00149.2015","article-title":"Intransasal scoplomanine affects the semi-circular canals centrally and peripherally","volume":"119","author":"Weerts","year":"2015","journal-title":"J. Appl. Physiol"},{"key":"B346","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1515\/JPM.2006.021","article-title":"Is the nausea and vomiting of early pregnancy really feto-protective?","volume":"34","author":"Weigel","year":"2006","journal-title":"J. Perinat. Med"},{"key":"B347","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0140-6736(78)90423-3","article-title":"General anaesthesia for high-dose total-body irradiation","volume":"1","author":"Whitwam","year":"1978","journal-title":"Lancet"},{"key":"B348","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/j.1476-5381.1995.tb13282.x","article-title":"The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro","volume":"114","author":"Wong","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"B349","unstructured":"WoodK. L. Aspects of the Central Control of Gastric Motility in the Ferret and the Rat1988"},{"key":"B350","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/BF03019133","article-title":"A comparative study of eleven anti-emetic drugs in dogs","volume":"9","author":"Wyant","year":"1962","journal-title":"Can. Anaesth. Soc. J."},{"key":"B351","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1007\/s00221-014-3937-6","article-title":"Integration of vestibular and emetic gastrointestinal signals that produce nausea and vomiting: potential contributions to motion sickness","volume":"232","author":"Yates","year":"2014","journal-title":"Exp. Brain Res"},{"key":"B352","doi-asserted-by":"publisher","first-page":"e104718","DOI":"10.1371\/journal.pone.0104718","article-title":"Serotonin 5-HT3 receptor-mediated vomiting occurs via the activation of Ca2+\/CaMKII-dependent ERK1\/2 signaling in the least shrew (Cryptotis parva)","volume":"9","author":"Zhong","year":"2014","journal-title":"PLoS ONE"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00913\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T21:09:50Z","timestamp":1751836190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00913\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":352,"alternative-id":["10.3389\/fphar.2018.00913"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00913","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,4]]},"article-number":"913"}}